Case report · 17 Jun 2019
Case reportPublished 15 Apr 2019
Influence of Abemaciclib, a New CDK 4/6 Inhibitor, Decrease in Potassium Electrollytes and Urea in a Patient Suffering from Metastatic Breast Cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A 46-year old patient suffering from metastatic breast cancer (FIGO IV D) underwent various chemotherapies and radiation treatments in the past. From November 4, 2018 the patient was treated with 300 mg Abemaciclib (2 × 150 mg). During therapy, her pain subjectively decreased. After 14 days the patient suffered nausea, emesis and exsiccation. She was therefore hospitalized and intensively monitored. Leukopenia and anemia on a common scale were treated in the usual way. Despite normal retentions, we detected a significant decrease in potassium and calcium. Surprisingly, we also detected a decrease in urea. Because of the continuous decrease in potassium and calcium, we substituted the electrolytes. After two weeks, all labor
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 16 Jan 2017
Inhibition of the Cyclin-Dependent Kinases (CDK) 4/6 as Therapy for Estrogen Receptor Positive Breast Cancer
Case report · 15 Oct 2024
Pathological Complete Response with CDK 4/6 Inhibitors in HR+/HER2- Locally Breast Cancer: Case of a Benign Bone Lesion Misidentified as Metastatic
Conference abstract · 7 Dec 2015
A new anti-cancer substance normalizing the blood picture in patients suffering from metastatic breast cancer stage IV
Article · 31 Jan 2026
Impact of the CDK4/6 Inhibitor Line of Use on Progression-Free Survival in HR+/HER2? Metastatic Breast Cancer: Real-Life Experience in Morocco
More from this journal
The newest in Journal of Clinical & Experimental Oncology.
Review article · 3 Jul 2025
Efficacy of interventions for newly diagnosed multiple myeloma: An umbrella review
Research article · 10 Apr 2025
Multitargets and Interactions of Wortmannin with MSC-Mitogenic Proteins Validate the Enhanced Antiproliferative Effect of MSCSecretome on Breast Cancer Michigan Cancer Foundation-7 Cells
Mini review · 24 Jan 2025
Fractal Analysis in Medical Images
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Zorn O”
- BylineArticles whose byline prints “Heirler F”

